This most recent twist within the Lykos Therapeutics saga threatens A serious overhaul of the business’s technique and path, with Musk ally and billionaire investor Antonio Gracias showing up to want to get the organization back towards its nonprofit drug advancement roots and a far more Doblinite philosophy., James writes about why so many peopl